US11166971B2ActiveUtilityA1
Methods of treating COVID-19 infection
Est. expiryMar 23, 2040(~13.7 yrs left)· nominal 20-yr term from priority
Inventors:Sabine Hazan
A61K 31/4706A61K 33/30A61P 31/14A61K 31/7052A61K 31/593A61K 31/375
91
PatentIndex Score
4
Cited by
94
References
3
Claims
Abstract
A method of treating an individual infected with COVID-19, the method comprising the steps of: providing an individual infected with COVID-19; administering five antimicrobials to the individual, wherein the antimicrobials comprise: hydroxychloroquine; azithromycin; vitamin C; vitamin D; and zinc; and monitoring the individuals condition over a pre-determined period of time to determine whether the individual is no longer infected with COVID-19.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of treating an individual infected with COVID-19, the method comprising the steps of:
a) providing an individual infected with COVID-19;
b) administering to the individual, on day 1:
i) two doses of 200 mg of hydroxychloroquine;
ii) one dose of 500 mg of azithromycin;
iii) one dose of 3,000 mg of vitamin C;
iv) one dose of 3,000 IU of vitamin D; and
v) one dose of 50 mg of zinc;
c) administering daily to the individual, on days 2 to 5:
i) two doses of 200 mg of hydroxychloroquine;
ii) one dose of 250 mg of azithromycin;
iii) one dose of 3,000 mg of vitamin C;
iv) one dose of 3,000 IU of vitamin D; and
v) one dose of 50 mg of zinc; and
d) administering daily to the individual, on days 6 to 10:
i) two doses of 200 mg of hydroxychloroquine;
ii) one dose of 3,000 mg of vitamin C;
iii) one dose of 3,000 IU of vitamin D; and
iv) one dose of 50 mg of zinc; and
e) monitoring the individuals condition over a pre-determined period of time to determine whether the individual is no longer infected with COVID-19.
2. The method of claim 1 , wherein step d) of administering on days 6 to 10 further comprises administering one dose of 250 mg of azithromycin.
3. The method of claim 1 , wherein the two doses of hydroxychloroquine in step b), step c), and step d) are administered as a single daily dose.Join the waitlist — get patent alerts
Track US11166971B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.